154 related articles for article (PubMed ID: 22324723)
21. Synthesis of novel 17-(5'-iodo)triazolyl-3-methoxyestrane epimers via Cu(I)-catalyzed azide-alkyne cycloadditon, and an evaluation of their cytotoxic activity in vitro.
Schneider G; Görbe T; Mernyák E; Wölfling J; Holczbauer T; Czugler M; Sohár P; Minorics R; Zupkó I
Steroids; 2015 Jun; 98():153-65. PubMed ID: 25732071
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
Pirali T; Busacca S; Beltrami L; Imovilli D; Pagliai F; Miglio G; Massarotti A; Verotta L; Tron GC; Sorba G; Genazzani AA
J Med Chem; 2006 Aug; 49(17):5372-6. PubMed ID: 16913727
[TBL] [Abstract][Full Text] [Related]
24. A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors.
Barnes NG; Parker AW; Ahmed Mal Ullah AA; Ragazzon PA; Hadfield JA
Bioorg Med Chem; 2020 Oct; 28(19):115684. PubMed ID: 32912434
[TBL] [Abstract][Full Text] [Related]
25. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
26. Antineoplastic agents 500. Narcistatin.
Pettit GR; Melody N; Simpson M; Thompson M; Herald DL; Knight JC
J Nat Prod; 2003 Jan; 66(1):92-6. PubMed ID: 12542352
[TBL] [Abstract][Full Text] [Related]
27. NQO1-selective activated prodrugs of combretastatin A-4: Synthesis and biological evaluation.
Zhang C; Qu Y; Ma X; Li M; Li S; Li Y; Wu L
Bioorg Chem; 2020 Oct; 103():104200. PubMed ID: 32890998
[TBL] [Abstract][Full Text] [Related]
28. Antineoplastic agents 389. New syntheses of the combretastatin A-4 prodrug.
Pettit GR; Rhodes MR
Anticancer Drug Des; 1998 Apr; 13(3):183-91. PubMed ID: 9595032
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonamidate clodronate prodrug exhibits potent anticancer activity in non-small-cell lung cancer cells.
Webster MR; Zhao M; Rudek MA; Hann CL; Freel Meyers CL
J Med Chem; 2011 Oct; 54(19):6647-56. PubMed ID: 21863853
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro antileukemic activity of some new 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives.
Siwy M; Sek D; Kaczmarczyk B; Jaroszewicz I; Nasulewicz A; Pelczyñska M; Nevozhay D; Opolski A
J Med Chem; 2006 Jan; 49(2):806-10. PubMed ID: 16420065
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma.
Stephenson AA; Cao S; Taggart DJ; Vyavahare VP; Suo Z
Eur J Med Chem; 2021 Mar; 213():113135. PubMed ID: 33454548
[TBL] [Abstract][Full Text] [Related]
34. Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors.
Ma Y; Wang T; Cheng L; Ma X; Li R; Zhang M; Chen J; Zhao P
Bioorg Med Chem Lett; 2024 Aug; 108():129816. PubMed ID: 38806101
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.
Hadimani MB; Macdonough MT; Ghatak A; Strecker TE; Lopez R; Sriram M; Nguyen BL; Hall JJ; Kessler RJ; Shirali AR; Liu L; Garner CM; Pettit GR; Hamel E; Chaplin DJ; Mason RP; Trawick ML; Pinney KG
J Nat Prod; 2013 Sep; 76(9):1668-78. PubMed ID: 24016002
[TBL] [Abstract][Full Text] [Related]
36. Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphate.
Roman CA; Balzarini J; Meier C
J Med Chem; 2010 Nov; 53(21):7675-81. PubMed ID: 20945915
[TBL] [Abstract][Full Text] [Related]
37. Novel combretastatin analogues endowed with antitumor activity.
Simoni D; Romagnoli R; Baruchello R; Rondanin R; Rizzi M; Pavani MG; Alloatti D; Giannini G; Marcellini M; Riccioni T; Castorina M; Guglielmi MB; Bucci F; Carminati P; Pisano C
J Med Chem; 2006 Jun; 49(11):3143-52. PubMed ID: 16722633
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents.
Alam MS; Nam YJ; Lee DU
Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364
[TBL] [Abstract][Full Text] [Related]
39. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
Akinboye ES; Rosen MD; Bakare O; Denmeade SR
Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, in vitro, and in vivo evaluation of phosphate ester derivatives of combretastatin A-4.
Hadimani MB; Hua J; Jonklaas MD; Kessler RJ; Sheng Y; Olivares A; Tanpure RP; Weiser A; Zhang J; Edvardsen K; Kane RR; Pinney KG
Bioorg Med Chem Lett; 2003 May; 13(9):1505-8. PubMed ID: 12699742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
